Your Health Today

FDA Approves Self-Collection Option for Cervical Cancer Screenings in Healthcare Settings

The FDA has approved a new self-collection method for cervical cancer screenings, offering patients an alternative to traditional pap smears and HPV tests. This advancement aims to improve early detection and accessibility, with companies like Beatty and Roche providing the tests.

By: NBC Palm Springs

September 6, 2024

FDA approvalselfcollection cervical cancer screeningpap smear alternativeHPV testearly detectioncervical cancerBeattyRochewomens health
Link Copied To Clipboard!
advertisement placeholder
Loading...